Jiahang Mo

415 total citations
15 papers, 255 citations indexed

About

Jiahang Mo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Jiahang Mo has authored 15 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Jiahang Mo's work include Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (3 papers) and PARP inhibition in cancer therapy (3 papers). Jiahang Mo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (3 papers) and PARP inhibition in cancer therapy (3 papers). Jiahang Mo collaborates with scholars based in China and Australia. Jiahang Mo's co-authors include Lihu Gu, Parikshit Asutosh Khadaroo, Bangsheng Chen, Tong Chen, Zefeng Shen, Lei Dong, Xiao Hu, Huihui Yu, Nannan Du and Min Shen and has published in prestigious journals such as Cell Death and Disease, Phytotherapy Research and Critical Reviews in Oncology/Hematology.

In The Last Decade

Jiahang Mo

15 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiahang Mo China 10 122 88 70 50 32 15 255
Xianglei Wu China 11 107 0.9× 90 1.0× 60 0.9× 34 0.7× 61 1.9× 27 355
Xian Jiang China 7 37 0.3× 159 1.8× 48 0.7× 55 1.1× 72 2.3× 13 328
Eiji Miyahara Japan 10 137 1.1× 116 1.3× 98 1.4× 81 1.6× 25 0.8× 44 395
Margaret Redpath Canada 8 70 0.6× 83 0.9× 36 0.5× 20 0.4× 20 0.6× 17 257
Xiaohong Xu China 9 73 0.6× 121 1.4× 59 0.8× 33 0.7× 72 2.3× 27 268
Chieh‐Hsiang Yang United States 7 77 0.6× 85 1.0× 21 0.3× 84 1.7× 41 1.3× 9 244
Janaina A. Pereira Brazil 3 165 1.4× 112 1.3× 44 0.6× 231 4.6× 27 0.8× 3 362
Emmy Yanagita Japan 13 94 0.8× 90 1.0× 71 1.0× 10 0.2× 72 2.3× 20 328
Mengqi Liu China 5 51 0.4× 164 1.9× 133 1.9× 28 0.6× 134 4.2× 9 276
Jun Meng China 11 115 0.9× 184 2.1× 75 1.1× 42 0.8× 136 4.3× 23 392

Countries citing papers authored by Jiahang Mo

Since Specialization
Citations

This map shows the geographic impact of Jiahang Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiahang Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiahang Mo more than expected).

Fields of papers citing papers by Jiahang Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiahang Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiahang Mo. The network helps show where Jiahang Mo may publish in the future.

Co-authorship network of co-authors of Jiahang Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Jiahang Mo. A scholar is included among the top collaborators of Jiahang Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiahang Mo. Jiahang Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Zhang, Min, et al.. (2024). The ovarian cancer-associated microbiome contributes to the tumor’s inflammatory microenvironment. Frontiers in Cellular and Infection Microbiology. 14. 1440742–1440742. 4 indexed citations
2.
Mo, Jiahang, et al.. (2024). CD47—a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features. World Journal of Surgical Oncology. 22(1). 44–44. 3 indexed citations
3.
Mo, Jiahang, et al.. (2023). Establishment and validation of a prediction nomogram for heart failure risk in patients with acute myocardial infarction during hospitalization. BMC Cardiovascular Disorders. 23(1). 619–619. 1 indexed citations
4.
Mo, Jiahang, et al.. (2023). A novel defined risk signature of endoplasmic reticulum stress-related genes for predicting the prognosis and immune infiltration status of ovarian cancer. Journal of Zhejiang University SCIENCE B. 24(1). 64–77. 11 indexed citations
5.
6.
Yang, Baicai, et al.. (2023). The combined signatures of G protein-coupled receptor family and immune landscape provide a prognostic and therapeutic biomarker in endometrial carcinoma. Journal of Cancer Research and Clinical Oncology. 149(16). 14701–14719. 3 indexed citations
7.
Mo, Jiahang, et al.. (2023). Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer. Cancer Control. 30. 2915577754–2915577754. 14 indexed citations
8.
Bian, Saiyan, Hui Wang, Jiahang Mo, et al.. (2022). CRMP2 derived from cancer associated fibroblasts facilitates progression of ovarian cancer via HIF-1α-glycolysis signaling pathway. Cell Death and Disease. 13(8). 675–675. 22 indexed citations
9.
10.
Gu, Lihu, Mian Wang, Jiahang Mo, et al.. (2020). Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection. BMC Surgery. 20(1). 24 indexed citations
11.
Mo, Jiahang, Xiao Hu, Lihu Gu, et al.. (2020). Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis. World Journal of Surgical Oncology. 18(1). 15–15. 57 indexed citations
12.
Gu, Lihu, Nannan Du, Qiong Jin, et al.. (2020). Magnitude of benefit of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for malignant tumor: A meta-analysis. Critical Reviews in Oncology/Hematology. 147. 102888–102888. 16 indexed citations
13.
Du, Nannan, Jing Jiang, Jiahang Mo, et al.. (2020). The efficacy and safety of the addition of poly ADP-ribose polymerase (PARP) inhibitors to therapy for ovarian cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 18(1). 151–151. 15 indexed citations
14.
Mo, Jiahang, et al.. (2020). A Meta-Analysis of Prognostic Factors in Patients with Posterior Circulation Stroke after Mechanical Thrombectomy. Cerebrovascular Diseases. 50(2). 185–199. 14 indexed citations
15.
Cui, Zhilei, Zhen Liu, Lei Chen, et al.. (2019). Eugenol inhibits non‐small cell lung cancer by repressing expression of NF‐κB‐regulated TRIM59. Phytotherapy Research. 33(5). 1562–1569. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xianglei Wu Breakdown of academic impact, for papers by Xian Jiang Breakdown of academic impact, for papers by Eiji Miyahara Breakdown of academic impact, for papers by Margaret Redpath Breakdown of academic impact, for papers by Xiaohong Xu Breakdown of academic impact, for papers by Chieh‐Hsiang Yang Breakdown of academic impact, for papers by Janaina A. Pereira Breakdown of academic impact, for papers by Emmy Yanagita Breakdown of academic impact, for papers by Mengqi Liu Breakdown of academic impact, for papers by Jun Meng
Rankless by CCL
2026